Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection

Author(s):  Allen Loyd V Jr

Issue:  May/Jun 2022 - Volume 26, Number 3
View All Articles in Issue

Abstract:  Parenteral solutions may include particulate matter that can be introduced from several different sources, including the active pharmaceutical ingredients, excipients, vehicles, cosolvents, buffers, preservatives, antioxidants, inert gases, surfactants, complexing agents, collecting agents, and others. Also, personnel involved in compounding parenteral drugs can be a source of particulates; this emphasizes the importance of adhering to proper compounding procedures in a proper environment during which compounding personnel should be properly garbed during the compounding. The container itself, whether it be plastic or glass, may also be a source of particulates. The identification of these particulates is important for the quality-control personnel to identify any issues that might be involved in adhering to required standards for sterile compounding. The United States Pharmacopeia has a number of chapters which are applicable to the compounding of sterile preparations, and the compounding personnel involved in compounding sterile preparations should be familiar with and adhere to the United States Pharmacopeia Chapter <797> standards for sterile preparations. The United States Pharmacopeia also includes inspecting injectable solutions, even though particulate matter testing presents many difficulties for the quality-control specialist. In addition to inspection and analysis of the parenteral solutions for the presence of foreign particulate matter, particulate matter testing includes procedures for removing, counting, and sizing contaminants in injections and ophthalmic solutions. There are four United States Pharmacopeia general chapters related to particulate matter in sterile products, including 1) Chapter <787> Subvisible Particulate Matter in Therapeutic Protein Injections, 2) Chapter <788> Particulate Matter in Injections, 3) Chapter <789> Particulate Matter in Ophthalmic Solutions, and 4) Chapter <790> Visible Particulates in Injection, all of which are discussed in this article.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, compounded sterile preparations, sterile compounding, aseptic compounding, parenteral solutions, particulates, contamination, contaminants, United States Pharmacopeia, injectables, drug admixtures, adjuvants, additives, solubility, stability, minimizing particulates, sorption, leaching, incompatibilities, pH, concentration, complexation, light sensitivity, reconstitution, mixing, filtration, visual inspection, packaging materials, polyvinyl chloride administration sets, storage conditions, quality control, particulate testing

Related Categories: ENVIRONMENTAL , PARENTERALS, STABILITIES, COMPATIBILITIES, STERILE PREPARATIONS, QUALITY CONTROL, UNITED STATES PHARMACOPEIA CONVENTIONS

Printer-Friendly Version




Download in electronic PDF format for $55

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection Allen Loyd V Jr May/Jun 2022 219-228 Buy
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D May/Jun 2004 181-185 Buy
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations Allen Loyd V Jr Nov/Dec 2021 491-496 Buy
Basics of Sterile Compounding: Particulate Matter Akers Michael J Sep/Oct 2017 395-404 Buy
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1 Allen Loyd V Jr Mar/Apr 2020 92 Buy
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Ashe Krystina, Baskett Dustin Sep/Oct 2018 387-398 Buy
Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Allen Loyd V Jr May/Jun 2020 215-220 Buy
Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation Allen Loyd V Jr Mar/Apr 2021 131-139 Buy
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, LlambĂ­ Francesc Jan/Feb 2014 6-12 Buy
Current Topical Treatments in Wound Healing - Part 1 Helmke Christopher D Jul/Aug 2004 269-274 Buy